mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0006 |
mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0006 |
mRNA |
Vandetanib |
CCLE |
pan-cancer |
AAC |
-0.17 |
0.0009 |
mRNA |
VNLG/124 |
GDSC1000 |
pan-cancer |
AAC |
-0.12 |
0.001 |
mRNA |
5-FU |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.001 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.001 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.001 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.001 |
mRNA |
PD-0325901 |
CCLE |
pan-cancer |
AAC |
-0.14 |
0.002 |
mRNA |
AC220 |
GDSC1000 |
pan-cancer |
AAC |
-0.12 |
0.002 |